No Data
Entero Therapeutics Grapples With Financial Strain and Compliance Issues
Express News | Entero Therapeutics - on Aug 2, Board Approved Termination of Employment Agreement, Dated Oct 8, 2019, by and Between Co and CEO James Sapirstein
Express News | Entero Therapeutics Inc - Exploring All Possibilities to Maximize Value for All of Company's Stakeholders
Express News | Entero Therapeutics Inc - Paused Any Non-Essential Research and Development Activities
Express News | Entero Therapeutics Inc - on August 1, Approved Termination of All Non-Essential Co Employees and Determined to Vacate Its Boca Raton Office
Express News | Entero Therapeutics Inc - Notice Informed Immunogenx That One or More Events of Default Under Credit Agreement Were Existing and Continuing
No Data